Abstract Providing NO-system importance, we suggest that one single application of the NOS-blocker L-NAME may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD
In the language of healing, it speaks directly to the bodys innate wisdoman invitation to return to balance
If you have already tried and failed first-line therapies or advanced biologics, subbing in an unverified peptide exposes you to a genuine risk of an uncontrolled disease flare
Hofmann NA, Ortner A, Jacamo RO, Reinisch A, Schallmoser K, Fruewirth M, Diwoky C, Rohban R, Beham-Schmid C, Andreeff M , Strunk D